Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Ovarian Neoplasms × TroVax × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 3 Carcinoma, Renal Cell 3 Recurrence 1 Prostatic Hyperplasia 1 Ovarian Neoplasms 1 Mesothelioma 1 Kidney Neoplasms 1 Fallopian Tube Neoplasms 1 Colorectal Neoplasms 1

Interventions

Paclitaxel 135 Carboplatin 130 Bevacizumab 86 Gemcitabine 45 pembrolizumab 37 olaparib 34 liposomal doxorubicin 30 Cisplatin 30 Docetaxel 29 Cyclophosphamide 29 Topotecan 28 niraparib 27 Taxes 21 Etoposide 18 Doxorubicin 17 Filgrastim 16 Immunoglobulin G 15 Disulfides 15 apatinib 12 Letrozole 12 Albumin-Bound Paclitaxel 12 Drug Therapy 11 fluzoparib 10 fludarabine 10 Specimen Handling 10 Magnetic Resonance Spectroscopy 10 Biopsy 10 durvalumab 9 Nivolumab 9 pazopanib 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01556841 2019-05-09

TRIOC

University College, London

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡